Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.800
-0.049 (-5.82%)
Apr 29, 2026, 11:30 AM EDT - Market open
Vivos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -21.17 | -11.14 | -13.58 | -23.85 | -20.29 | |
| Depreciation & Amortization | 1.31 | 0.58 | 0.62 | 0.67 | 0.73 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.04 | - | |
| Stock-Based Compensation | 0.66 | 0.79 | 1.84 | 3.11 | 2.91 | |
| Other Operating Activities | -0.06 | 0.01 | -3.69 | -1.27 | 0.88 | |
| Change in Accounts Receivable | -0.22 | -0.23 | 0.26 | 0.75 | 0.23 | |
| Change in Accounts Payable | 0.52 | -1.05 | 0.73 | 0.49 | 0.14 | |
| Change in Unearned Revenue | -0.51 | -1.43 | -0.61 | 0.64 | -0.54 | |
| Change in Other Net Operating Assets | 4.2 | -0.23 | 2.49 | -0.16 | 0.2 | |
| Operating Cash Flow | -15.26 | -12.69 | -11.95 | -19.59 | -15.74 | |
| Capital Expenditures | -2.34 | -0.57 | -0.85 | -0.92 | -2.4 | |
| Cash Acquisitions | -5.19 | - | - | - | -0.23 | |
| Other Investing Activities | - | - | - | - | 0.01 | |
| Investing Cash Flow | -7.53 | -0.57 | -0.85 | -0.92 | -2.61 | |
| Long-Term Debt Issued | 10.67 | - | - | - | - | |
| Long-Term Debt Repaid | -0.03 | - | - | - | -0.03 | |
| Net Debt Issued (Repaid) | 10.65 | - | - | - | -0.03 | |
| Issuance of Common Stock | 8.75 | 19.24 | 12 | - | 27.93 | |
| Other Financing Activities | -0.84 | -1.36 | -1.08 | - | -2.24 | |
| Financing Cash Flow | 18.56 | 17.88 | 10.92 | - | 24.17 | |
| Net Cash Flow | -4.23 | 4.62 | -1.88 | -20.51 | 5.82 | |
| Free Cash Flow | -17.6 | -13.26 | -12.8 | -20.51 | -18.13 | |
| Free Cash Flow Margin | -100.92% | -88.21% | -92.74% | -128.00% | -107.38% | |
| Free Cash Flow Per Share | -1.71 | -2.64 | -10.50 | -22.28 | -21.35 | |
| Cash Interest Paid | - | 0.01 | - | - | 0.02 | |
| Levered Free Cash Flow | -9.41 | -8.84 | -8.61 | -11.25 | -11.27 | |
| Unlevered Free Cash Flow | -9.41 | -8.84 | -8.61 | -11.25 | -11.26 | |
| Change in Working Capital | 4 | -2.94 | 2.86 | 1.71 | 0.03 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.